Semtech Launches New ClearEdge™ CDR for 100G QSFP28 Modules at OFC 2017
Mar 20, 2017 12:02 pm UTC| Business
Ultra-low power, high-performance ClearEdge CDR expands portfolio of optical networking products for next-generation data centers and enterprise network infrastructure ...
Semtech Launches New ClearEdge™ CDR for 100G QSFP28 Modules at OFC 2017
Mar 20, 2017 12:02 pm UTC| Business
Ultra-low power, high-performance ClearEdge CDR expands portfolio of optical networking products for next-generation data centers and enterprise network infrastructure ...
Semtech Announces Integrated Chipset for Next-Generation 100G QSFP28 Modules
Mar 20, 2017 12:01 pm UTC| Business
New chipset enables high-performance, low-power modules for data communications; Live demonstration at OFC 2017 ...
Semtech Announces Integrated Chipset for Next-Generation 100G QSFP28 Modules
Mar 20, 2017 12:01 pm UTC| Business
New chipset enables high-performance, low-power modules for data communications; Live demonstration at OFC 2017 ...
Semtech Demonstrates New 53GBaud PAM4 Linear Driver and Transimpedance Amplifier at OFC 2017
Mar 20, 2017 12:01 pm UTC| Business
High-performance IC platform supports next-generation 100G optical networking modules ...
Semtech Demonstrates New 53GBaud PAM4 Linear Driver and Transimpedance Amplifier at OFC 2017
Mar 20, 2017 12:01 pm UTC| Business
High-performance IC platform supports next-generation 100G optical networking modules ...
Mar 20, 2017 12:01 pm UTC| Business
NEW YORK, March 20, 2017 -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that preclinical data on its anti-PD-L1 antibody and EGFR inhibitor...